and Virginie Badon of the Centre dInvestigation Clinique CIC 1413, INSERM, CHU de Nantes
The glutamate N -methyl-D-aspartate receptor (NMDAR) antagonist ketamine was recently repurposed as a rapidly acting antidepressant, catalysing the vigorous investigation of glutamate-signalling modulators as novel therapeutic agents for depressive disorders
These shots are administered via intramuscular injection (often referred to as IM) so there is no gastrointestinal metabolism, which also allows for increased nutritional absorption
doi: 10.3390/nu13061848 6 ArentzSSmithCAAbbottJBensoussanA
Most available data comes from animal research, laboratory studies, or limited early-stage investigation, which describe how these peptides may affect healing pathways rather than long-term clinical outcomes in humans
Explore Move into detailed research Use related articles, citations, and category pages to keep researching the safest fit